View source for Medicine:Stroke in China

Recent epidemiologic studies confirm that [[Medicine:Stroke|stroke]] is the most frequent [[Cause of death|cause of death]] in the People's Republic of China, with an incidence more than fivefold that of [[Medicine:Myocardial infarction|myocardial infarction]]. [[Medicine:Intracerebral hemorrhage|Intracerebral hemorrhage]] causes about one third of all strokes, nearly three times the frequency in North American stroke registries. A marked regional variation in stroke incidence exists, with a threefold higher stroke incidence in northern than in southern Chinese cities, suggesting important environmental or dietary influences. Stroke treatment often involves a combination of modern and traditional herbal medicine; the latter may modify platelet aggregation and [[Medicine:Blood viscosity|blood viscosity]]. Stroke, particularly intracerebral hemorrhage, is the most frequent and important vascular disorder in China.
{{wipe|China}} reports more patients with [[Medicine:Stroke|stroke]] than anywhere else in the world. While there is still a great deal of unknown information, stroke research has been making great progress in recent years, such as in the areas of clinical research, population and genetic epidemiology, brain ischemia/reperfusion exploring, leukoencephalopathy (CADASIL), neural stem cell and stroke, neuroprotective treatment for stroke, clinical therapy test in stroke, rehabilitation and prevention. 

Cities and towns in China have integrated systems for registering and investigating strokes. Chinese researchers have followed closely the international level of stroke treatment with a forward position in neural stem cell. [[Medicine:Traditional Chinese medicine|Traditional Chinese drugs]] have featured effects on neuroprotective treatment for stroke which has also been investigated. Chinese scientists have suggested a new way of dividing neuroprotectors in stroke. The clinical therapy test with urokinase and defibrase for cerebral infarction in China is effective and relatively safe, yet the original papers published by Chinese researchers and clinical effects for patient treatment still need to be improved and updated.

==Epidemiology==
[[Medicine:Stroke|Stroke]] is the second most common cause of death and leading cause of adult disability in China.<ref name="The global stroke initiative.">Bonita R, Mendis S, Truelsen T, Bogousslavsky J, Toole J, Yatsu F. The global stroke initiative. Lancet Neurol 2004; 3: 391-393.</ref> Chronic diseases now account for an estimated 80% of deaths and 70% of disability-adjusted life-years lost in China. 

The major causes of death in China are [[Medicine:Vascular disease|vascular disease]], [[Medicine:Cancer|cancer]], and chronic [[Medicine:Respiratory disease|respiratory disease]].<ref name="Preventing chronic diseases in China.">Wang LD, Kong LZ, Wu F, Bai YM, Burton R. Preventing chronic diseases in China. Lancet 2005; 366: 1821-1824.</ref> Unlike in western countries, cerebrovascular disease predominates; the number of patients who die from stroke is more than three times that from coronary heart disease.<ref name="Sino-MONICA project">Wu ZS, Yao CH, Zhao D, et al. [http://circ.ahajournals.org/cgi/content/full/circulationaha;103/3/462 Sino-MONICA project A collaborative study on trends and determinants in cardiovascular diseases in China, part I: morbidity and mortality monitoring.] Circulation 2001; 103: 462-468.</ref> 

In the past 20 years, China has experienced a rapid [[Finance:Economic development|economic development]]. Over time, the proportion of elderly people in the population will likely increase, [[Biology:Life expectancy|life expectancies]] will lengthen, and, as in some other developing countries, the influence of a westernized lifestyle might shift disease patterns towards a profile more similar to that seen in more developed regions, so that the number of strokes will rise.<ref name="Sino-MONICA project"/>

Total age-adjusted incidence of first-ever stroke in China is not very different from that in developed countries. Stroke incidence, mortality, and prevalence varies widely among different regions within China, with a noticeable north–south [[Gradient|gradient]]. The proportion of intracerebral haemorrhage was high and reached 55% in one city.<ref name="Sino-MONICA project"/>

[[Medicine:Hypertension|Hypertension]] is the most important [[Medicine:Risk factor|risk factor]] for stroke. The mass approach combined with a high-risk approach for stroke prevention showed encouraging effects, and various [[Medicine:Traditional Chinese medicine|unconventional local therapeutic traditions]] are commonly used to treat stroke in China.<ref name="Preventing chronic diseases in China."/>

Several [[Medicine:Medical guideline|national guidelines]] on stroke prevention and treatment have been developed. Because of methodological limitations in the [[Social:Epidemiology|epidemiology]] studies, official government data have been unreliable in terms of making any firm conclusions. There have been calls for urgently needed up-to-date, well-designed, and well-done epidemiological studies and therapeutic trials in China.<ref name="The global stroke initiative."/>

==Further reading==
*M. Liu, B. Wu, W. Wang, L. Lee, S. Zhang, L. Kong. [http://www.thelancet.com/journals/laneur/article/PIIS1474442207700042/fulltext Stroke in China: epidemiology, prevention, and management strategies .] ''Lancet Neurology'' 2007; 6:456-464
*[http://www.ingentaconnect.com/content/maney/nres/2006/00000028/00000001/art00002 Stroke research in China] Neurological Research, Volume 28, Number 1, January 2006, pp.&nbsp;11–15(5)
*Thomas Truelsen. [http://stroke.ahajournals.org/cgi/content/full/strokeaha;39/6/1653 Epidemiological Transition of Stroke in China?] (Stroke. 2008;39:1653.)
* Dong Zhao, Jing Liu, Wei Wang, Zhechun Zeng, Jun Cheng, Jun Liu, Jiayi Sun, and Zhaosu Wu [http://stroke.ahajournals.org/cgi/content/abstract/39/6/1668 Epidemiological Transition of Stroke in China: Twenty-One–Year Observational Study From the Sino-MONICA-Beijing Project]  Stroke, June 2008; 39: 1668 - 1674.
*[http://content.karger.com/ProdukteDB/produkte.asp?Doi=110902 Stroke in China (Sino-MONICA-Beijing Study) 1984-1986] Neuroepidemiology 1992;11:15-23 {{doi|10.1159/000110902}}
* [http://www.ingentaconnect.com/content/bsc/ijs/2007/00000002/00000003/art00011 Burden of stroke in China] International Journal of Stroke, Volume 2, Number 3, August 2007, pp.&nbsp;211–213(3)
*[http://stroke.ahajournals.org/cgi/content/abstract/30/3/495 Prevention of Stroke in Urban China: A Community-Based Intervention Trial] (Stroke. 1999;30:495-501.)
*[http://stroke.ahajournals.org/cgi/content/abstract/01.STR.0000087149.42294.8Cv1 Proportion of Different Subtypes of Stroke in China] Stroke. 2003
*[http://www.biomedcentral.com/1471-2350/8/60/abstract The Fangshan/Family-based Ischemic Stroke Study In China (FISSIC) protocol] BMC Medical Genetics 2007, 8:60
*Gelin Xu. [http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=119636&Ausgabe=234550&ProduktNr=224153&filename=119636.pdf Building a Platform for East-West Communication in Stroke Research: Report of the Third International Stroke Summit, Wuhan, China, November 1–3, 2007] ''Cerebrovasc Dis'' 2008;25:279–280

;Stroke Journals

*''[http://stroke.ahajournals.org/ Stroke]'' AHA
*International Journal of Stroke [http://www.blackwellpublishing.com/journal.asp?ref=1747-4930&site=1]
*http://www.basp.ac.uk
*http://bmj.com
*http://jama.ama-assn.org
*http://www.strokejournal.org

==See also==
*[[Engineering:Clinical trial|Clinical trial]]
*[[Medicine:Good clinical practice|good clinical practice]]
*[[Medicine:Clinical research associate|Clinical research associate]]
*International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use
*[[Medicine:Health informatics|Health informatics]]
*National Institute for Health and Clinical Excellence - UK
*CHIMES Society - Singapore NGO

==References==
{{Reflist|2}}

==External links==

;Organizations
*[http://www.zhongfeng.cn/ China Stroke hemiplegia Network]
*[http://www.zgzfw.net/ Chinese Stroke Network]

;Articles
*[http://www.strokesafe.org/resources/stroke_trek/chapt3.html The "State of Stroke" in China] Stroke Awareness for Everyone SAFE (August 2000)
*[http://www.medscape.com/viewarticle/571037 China's Economic Prosperity Parallels Rising Stroke Rate] March 5, 2008
*[http://www.eurekalert.org/pub_releases/2008-03/aha-sim030608.php Smoking is major risk factor for stroke in China]
*[http://www.world-stroke.org/ World Stroke Organization], merger of International Stroke Society ISS and the World Stroke Federation (WSF)
*[https://web.archive.org/web/20040821054545/http://www.dcn.ed.ac.uk/csrg/csgpubs.asp Cochrane Stroke Group] International Conference on Stroke, Chengdu, China, 10–12 March 2007 [https://web.archive.org/web/20090410061023/http://www.dcn.ed.ac.uk/csrg/presentations/wso2006chinese/player.html Chinese Audio]
*[https://web.archive.org/web/20080822004108/http://pt.usc.edu/SubLayout.aspx?menu_id=68&id=150 Stroke Rehabilitation in China] University of Southern California
*[http://www.strokeassociation.org/presenter.jhtml?identifier=3037585 A Chinese Stroke Connection - The Ruth Lycke Story] March/April 2006
*[http://www.neurology-asia.org/articles/20061_005.pdf Setting priorities in Asian stroke research]

{{Health in the People's Republic of China}}

[[Category:Stroke]]

{{Sourceattribution|Stroke in China}}